Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2025 · 10-Q
Revenue$89.41M$89.41M−36.2% vs Q3 2024 Net Income-$2.26M-$2.26MN/M vs Q3 2024 EPS Diluted-$0.21-$0.21N/M vs Q3 2024 Gross Profit$62,159,000−41.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$12,113,000+33.5% Free Cash Flowderived$10,750,000+39.9% Margins · derivedGross margin69.5%−5.9 pt vs Q3 2024
Operating margin-4.6%−6.1 pt vs Q3 2024
Net margin-2.5%−3.3 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 3, 2025 · 34 d after period end